Non-EB RX Thread: Miller Buckfire v. Ducera v. GLC v. TRS v Gordian

Can anyone speak on the merits of these shops with regards to each other? Are any of them better than the other with regards to deal flow/exposure, culture, exit opps, comp etc? How strong are they in the RX world?

 

Ducera is quite strong, preference for creditor work ex. Neiman Marcus, also do M&A from time to time although work environment might not be for everyone. Have heard anecdotally that pay is quite good. In some ways, based just on employees/scale and deals they have recently done, might be best of the group OP listed but I'll leave that up to others to decide. 

 

These are very different firms in terms of breadth of mandate and work environment, there's no reason to group them separately from rx practices with coverage support (especially given TRS already sold).

 

Gordian isn’t the same tier as the rest of these. Ducera does some cool creditor work and TRS does too.

 

Miller Buckfire is nowhere near where it used to be. Really fell off shortly after the financial crisis and doesn’t get most of the big deals anymore. I believe mostly creditor side but I can’t remember exactly. Most of the top bankers left years ago and are now high up in other rx shops (EVR, GUGG, CVP, to name a few).

 

LMFAO Gordian Group is nowhere near the rest of these, they have one MD who’s semi-decent but that’s about all they have going for them. TRS and Ducera are both solid shops that will allow you to exit decently or at the very least, lateral to a better bank.

 

If someone were to apply to your firm, since you're at a distressed/SS fund, what would be more valuable: someone with RX experience at a shop you never heard of or someone with M&A/coverage group experience at a place you have heard of? Wondering to what extent name brand outweighs the relevancy/similarity of prior work experience to what your fund does. 

 

Earum est aut inventore qui ullam. Quis iste aut aperiam eos quo est quia et. Atque quibusdam quia saepe quod numquam.

Ipsam est ad perferendis. Iusto est labore temporibus ipsa. Exercitationem eos dolores et perspiciatis. Id voluptates doloribus necessitatibus non dolorem eos quia.

Quos aut eius aperiam illum. In sint dolor commodi facilis. Libero repellendus porro atque illo et consequuntur voluptatem. Voluptate magni eos qui dicta excepturi.

At laborum expedita necessitatibus debitis dolor. Eum in consequatur vitae non et ducimus qui culpa.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (20) $385
  • Associates (88) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (67) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
kanon's picture
kanon
98.9
9
bolo up's picture
bolo up
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”